• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Aceto Updates Information Regarding Its Initiative to Provide Vaccines for Companion Animals

Posted on: Wednesday, 27 September 2006, 09:01 CDT

Aceto Corporation (NASDAQ:ACET), a global leader in the sourcing,

distribution and marketing of chemically-derived pharmaceuticals,

biopharmaceuticals, specialty chemicals and agrochemicals, today updated

previously announced information regarding its companion animal vaccines

initiative.

Leonard S. Schwartz, Chairman, CEO, and President of Aceto, stated, "On

September 8, 2006, we announced our fiscal 2006 results and discussed

the status of our initiative to provide vaccines for companion animals.

We stated that we expected USDA approval by the end of calendar 2006. On

our corresponding conference call, in response to a question and based

on misinformation we received from our European supplier, we mentioned

that final animal testing had begun, with the animals being inoculated

on September 2nd and 3rd.

We also said we expected to file the results of testing with the USDA

around October 10th --

15th."

"Subsequent to the conference call, it has

come to our attention that the animals had not yet been inoculated, but

rather were in the process of being acclimated, the final step in the

process before the inoculations. It has also come to our attention that

the animal testing has to be run consecutively rather than concurrently,

and therefore the results of the final testing will not be made

available to the USDA until at least February 2007."

Mr. Schwartz added, "We are doing everything

we can to expedite the USDA approval process. We remain ready to

implement our marketing program and immediately enter the market with

Aceto branded product, subject to receiving USDA approval."

ABOUT ACETO

Aceto Corporation, incorporated in 1947, is a global leader in the

sourcing, distribution and marketing of chemically-derived

pharmaceuticals, biopharmaceuticals, specialty chemicals and

agrochemicals. With a presence in ten countries, we distribute over

1,000 chemicals used principally as raw materials in the pharmaceutical,

agricultural, color, surface coating/ink and general chemical consuming

industries.

This news release contains forward-looking statements within the meaning

of Section 27A of the Securities Act of 1933, as amended, and Section

21E of the Securities Exchange Act of 1934, as amended. These

forward-looking statements are based on current expectations, estimates

and projections of management. Aceto intends for these forward-looking

statements to be covered by the safe-harbor provisions for

forward-looking statements. Words such as "anticipates,""expects,"

"intends,""plans,""believes,""seeks,""estimates," or variations of

such words are intended to identify such forward-looking statements. The

forward-looking statements contained in this press release include, but

are not limited to, statements regarding approval of applications for,

and entering the market for veterinary vaccines. All forward-looking

statements in this press release are made as of the date of this press

release, and Aceto assumes no obligation to update these forward-looking

statements whether as a result of new information, future events or

otherwise, other than as required by law. The forward-looking statements

are subject to risks and uncertainties that could cause actual results

to differ materially from those set forth or implied by any

forward-looking statements. These uncertainties include, but are not

limited to, competitive product offerings and pricing actions, the

availability and pricing of key raw materials, dependence on key members

of management, economic and political conditions in the United States

and abroad, as well as other risks detailed in the Company's SEC

reports, including the Company's Form 10-K and other filings. Copies of

these filings are available at www.sec.gov.

Source: Business Wire

More News in this Category